Home pagePTKFY • OTCMKTS
add
PT Kalbe Farma Unsponsored Indonesia ADR
Chiusura precedente
19,94Â $
Intervallo annuale
16,38Â $ - 23,73Â $
Cap di mercato
71,03Â Bln IDR
Volume medio
1126,00
Notizie del mercato finanziario
Dati finanziari
Conto economico
Entrate
Utile netto
(IDR) | set 2024info | Variazione Y/Y |
---|---|---|
Entrate | 7,91Â Bln | 7,16% |
Spese di gestione | 2,29Â Bln | 15,55% |
Utile netto | 573,28Â Mld | 6,97% |
Margine di profitto netto | 7,25 | -0,14% |
Utili per azione | 12,41 | 7,73% |
EBITDA | 874,81Â Mld | 1,14% |
Aliquota fiscale effettiva | 23,01% | — |
Stato patrimoniale
Totale attivo
Totale passivo
(IDR) | set 2024info | Variazione Y/Y |
---|---|---|
Investimenti cash/breve termine | 4,32Â Bln | 45,45% |
Totale attivo | 28,75Â Bln | 5,78% |
Totale passivo | 4,84Â Bln | 0,67% |
Patrimonio netto totale | 23,91 Bln | — |
Azioni in circolazione | 46,15 Mld | — |
Prezzo/valore contabile | 0,04 | — |
Redditività dell'attivo | 6,15% | — |
Rendimento sul capitale | 7,16% | — |
Flusso di cassa
Flusso di cassa netto
(IDR) | set 2024info | Variazione Y/Y |
---|---|---|
Utile netto | 573,28Â Mld | 6,97% |
Liquidità di esercizio | 1,16 Bln | 22,56% |
Contanti da investimenti | -176,64Â Mld | 33,78% |
Contanti da finanziamenti | -421,11Â Mld | 51,91% |
Flusso di cassa netto | 481,86Â Mld | 1.978,42% |
Flusso di cassa libero | 752,00Â Mld | 13,84% |
Informazioni
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. Wikipedia
Fondazione
10 set 1966
Sito web
Dipendenti
12.924